Literature DB >> 18095093

Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.

Jun-ichiro Sekiguchi1, Katsuji Teruya, Kumi Horii, Emi Kuroda, Hisami Konosaki, Yukie Mizuguchi, Minako Araake, Akihiko Kawana, Hiroshi Yoshikura, Tadatoshi Kuratsuji, Hisayoshi Miyazaki, Teruo Kirikae.   

Abstract

We witnessed outbreaks of multidrug-resistant (MDR) and drug-resistant Pseudomonas aeruginosa at a hospital in Tokyo, Japan, during the period September 2004 through May 2005. The first outbreak occurred in September and October 2004. Three isolates of MDR P. aeruginosa were identified from urine samples obtained from three nonambulatory immunodeficient patients in one ward. After 3 weeks, another outbreak of P. aeruginosa occurred in the hematology ward on the same floor of the hospital. During the outbreaks, environmental surveys were conducted twice in each of the two wards, at 2-week intervals, to identify the sources of the pathogens. A total of 23 P. aeruginosa isolates, including 11 from environmental sources, were analyzed for chromosomal DNA typing by pulsed-field gel electrophoresis, for O-antigen serotyping, and for other typing. Results revealed two causative clones, as well as environmental contamination by P. aeruginosa clones on the surfaces of urine volume-measuring devices in rooms where urine is handled, which may have been sources of the pathogens during the outbreaks. To prevent further outbreaks, we performed the following: (a) environmental surface monitoring for drug-resistant P. aeruginosa, (b) active surveillance of specimens, (c) strict isolation of infected patients or carriers of MDR P. aeruginosa, (d) rigorous contact precautions, and (e) disinfection with 70% alcohol on the surfaces of apparatuses contaminated by MDR or drug-resistant P. aeruginosa and in the rooms where urine is handled. As a result, the outbreaks were contained.

Entities:  

Mesh:

Year:  2007        PMID: 18095093     DOI: 10.1007/s10156-007-0560-5

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  11 in total

1.  Genome sequence of multidrug-resistant Pseudomonas aeruginosa NCGM1179.

Authors:  Tatsuya Tada; Tomoe Kitao; Tohru Miyoshi-Akiyama; Teruo Kirikae
Journal:  J Bacteriol       Date:  2011-11       Impact factor: 3.490

2.  Complete genome sequence of highly multidrug-resistant Pseudomonas aeruginosa NCGM2.S1, a representative strain of a cluster endemic to Japan.

Authors:  Tohru Miyoshi-Akiyama; Tomoko Kuwahara; Tatsuya Tada; Tomoe Kitao; Teruo Kirikae
Journal:  J Bacteriol       Date:  2011-12       Impact factor: 3.490

3.  Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012.

Authors:  Wataru Shimizu; Shizuo Kayama; Shuntaro Kouda; Yoshitoshi Ogura; Kanao Kobayashi; Norifumi Shigemoto; Norimitsu Shimada; Raita Yano; Junzo Hisatsune; Fuminori Kato; Tetsuya Hayashi; Taijiro Sueda; Hiroki Ohge; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

Review 4.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.

Authors:  Tomoe Kitao; Tohru Miyoshi-Akiyama; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

6.  Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels.

Authors:  Yoshimi Matsumoto; Kohei Hayama; Shouichi Sakakihara; Kunihiko Nishino; Hiroyuki Noji; Ryota Iino; Akihito Yamaguchi
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

7.  A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitors.

Authors:  Ryota Iino; Kunihiko Nishino; Hiroyuki Noji; Akihito Yamaguchi; Yoshimi Matsumoto
Journal:  Front Microbiol       Date:  2012-02-08       Impact factor: 5.640

8.  A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa.

Authors:  Yoshimi Matsumoto; Shouichi Sakakihara; Andrey Grushnikov; Kazuma Kikuchi; Hiroyuki Noji; Akihito Yamaguchi; Ryota Iino; Yasushi Yagi; Kunihiko Nishino
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

9.  Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates.

Authors:  Po-Liang Lu; L K Siu; Tun-Chieh Chen; Ling Ma; Wen-Gin Chiang; Yen-Hsu Chen; Sheng-Fung Lin; Tyen-Po Chen
Journal:  BMC Infect Dis       Date:  2009-10-01       Impact factor: 3.090

10.  Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.

Authors:  Seiji Kobayashi; Hoichi Amano; Hiroyuki Terawaki; Makoto Ogura; Yoshindo Kawaguchi; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2019-08-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.